Literature DB >> 19549926

Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system.

Natsuko Tsujino1, Takeshi Sakurai.   

Abstract

Recent studies have implicated the orexin system as a critical regulator of sleep/wake states as well as feeding behavior and reward processes. Orexin deficiency results in narcolepsy in humans, dogs, and rodents, suggesting that the orexin system is particularly important for maintenance of wakefulness. In addition, orexin deficiency also cause abnormalities in energy homeostasis and reward systems. Orexin activates waking active monoaminergic and cholinergic neurons in the hypothalamus and brainstem regions to maintain a long, consolidated waking period. Orexin neurons receive abundant input from the limbic system. Orexin neurons also have reciprocal links with the hypothalamic arcuate nucleus, which regulates feeding. Moreover, the responsiveness of orexin neurons to peripheral metabolic cues, such as leptin and glucose, suggest that these neurons have important role as a link between the energy homeostasis and vigilance states. Orexin neurons also have a link with the dopaminergic reward system in the ventral tegmental nucleus. These findings suggest that the orexin system interacts with systems that regulate emotion, reward, and energy homeostasis to maintain proper vigilance states. Therefore, this system may be a potentially important therapeutic target for treatment of sleep disorder, obesity, emotional stress, and addiction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549926     DOI: 10.1124/pr.109.001321

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  160 in total

1.  The sleep-wake cycle and motor activity, but not temperature, are disrupted over the light-dark cycle in mice genetically depleted of serotonin.

Authors:  Julia Z Solarewicz; Mariana Angoa-Perez; Donald M Kuhn; Jason H Mateika
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-12       Impact factor: 3.619

Review 2.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

3.  The association between short sleep duration and weight gain is dependent on disinhibited eating behavior in adults.

Authors:  Jean-Philippe Chaput; Jean-Pierre Després; Claude Bouchard; Angelo Tremblay
Journal:  Sleep       Date:  2011-10-01       Impact factor: 5.849

4.  Short sleep duration promoting overconsumption of food: A reward-driven eating behavior?

Authors:  Jean-Philippe Chaput
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

5.  Evolutionarily conserved regulation of hypocretin neuron specification by Lhx9.

Authors:  Justin Liu; Florian T Merkle; Avni V Gandhi; James A Gagnon; Ian G Woods; Cindy N Chiu; Tomomi Shimogori; Alexander F Schier; David A Prober
Journal:  Development       Date:  2015-02-27       Impact factor: 6.868

6.  Tumor necrosis factor-alpha regulates the Hypocretin system via mRNA degradation and ubiquitination.

Authors:  Shuqin Zhan; Guo-Qiang Cai; Anni Zheng; Yuping Wang; Jianping Jia; Haotian Fang; Youfeng Yang; Meng Hu; Qiang Ding
Journal:  Biochim Biophys Acta       Date:  2010-11-18

Review 7.  It's complicated: The relationship between sleep and Alzheimer's disease in humans.

Authors:  Brendan P Lucey
Journal:  Neurobiol Dis       Date:  2020-07-29       Impact factor: 5.996

8.  Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency.

Authors:  S P Deats; W Adidharma; J S Lonstein; L Yan
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

9.  The effects of amphetamine injections on feeding behavior and the brain expression of orexin, CART, tyrosine hydroxylase (TH) and thyrotropin releasing hormone (TRH) in goldfish (Carassius auratus).

Authors:  Hélène Volkoff
Journal:  Fish Physiol Biochem       Date:  2012-12-11       Impact factor: 2.794

Review 10.  Therapeutics development for addiction: Orexin-1 receptor antagonists.

Authors:  David A Perrey; Yanan Zhang
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.